FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20240715E00026
1. Date of relevant event: 10/07/2024
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 02228
4. Name of listed corporation: QuantumPharm Inc. - P 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 3,415,568,761
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Wen
(Other names) Shu Hao
10. Name of director (Chinese): 温书豪 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1711Miscellaneous
Other (you must briefly describe the relevant event in the Supplementary Information box)
 
2201Interest of corporation controlled by you
 
2201Interest of corporation controlled by you
 
730,890,183         
 
Short position 
1312There has been a change in nature of your interest in the shares because:
the shares lent by you have been returned to you
 
2101Beneficial owner
 
 
28,105,000           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position730,890,18321.45
Short position28,105,0000.82
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position730,890,18321.40
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position81,093,362
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position222,126,400
2201Interest of corporation controlled by you
Long position508,763,783
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
           
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
QuantumPharm Roc Holdings LimitedSertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsQuantumPharm Holdings Limited100.00Y
Long position298,041,143
Crete Helix Ltd.Sertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsMH International Holdings Limited99.00Y
Long position122,908,500
SeveningBAlpha LimitedSertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsLPHappy Holding Limited99.00Y
Long position87,814,140
WSH Family Holdings LimitedCoastal Building, Wickham's Cay II, P. O. Box 2221, Road Town, Tortola, British Virgin Island温书豪100.00N
Long position222,126,400
QuantumPharm Holdings LimitedSertus Chambers, P.O. Box 905, Quastisky Building, Road Town, Tortola, British Virgin IslandsWSH Family Holdings Limited99.00Y
Long position222,126,400
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
WSH Family TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position222,126,400
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: 方格24:由于行使超额配售权额外发行8,796,000股份,温书豪持有的股份比例改变;及借予稳市商用于补足国际发售下超额分配的28,105,000股份已获归还。方格27及30:根据马健与Crete Helix Ltd.及赖力鹏与SeveningBAlpha Limited签订的授权书,QuantumPharm Holdings Limited获授权行使由彼等持有股份的投票权。温书豪及QuantumPharm Holdings Limited被视为拥有Crete Helix Ltd. 持有的122,908,500股份及SeveningBAlpha Limited持有的87,814,140股份的权益。MH International Holdings Limited的权益由其信托成立人马健控制。LPHappy Holding Limited的权益由其信托成立人赖力鹏控制。温书豪被视为拥有首次公开发售前员工持股计划持股平台QuantumPharm Roc Holding Limited持有的298,041,143股份的权益并于首次公开发售前员工持股计划中享有81,093,362股份的购股权。
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 15/07/2024
(dd/mm/yyyy)